Rapilief 4 Capsule

About Rapilief 4 Capsule

Rapilief 4 is a capsule containing the generic medicine silodosin. It belongs to a group of medicines called alpha-blockers and is used for men with urinary symptoms caused by an enlarged prostate.

There are 6 brands of Silodosin listed in Bangladesh.

What is Rapilief 4 Capsule?

Rapilief 4 is a capsule made by Nuvista Pharma Ltd. It contains silodosin, an alpha-blocker that works on receptors in the prostate and bladder area, helping the muscles there to relax. This can improve urine flow and ease urinary symptoms in men with benign prostatic hyperplasia, also called BPH. It is not a treatment for high blood pressure. The capsule is available in a 4 mg strength. Your doctor will decide whether this medicine is suitable for you and how long you should take it.

Uses of Rapilief 4

Rapilief 4 is used to treat the signs and symptoms of benign prostatic hyperplasia in men. This is a non-cancerous enlargement of the prostate gland that can make passing urine difficult or frequent. By relaxing certain muscles around the prostate and bladder, the medicine may help urine flow more easily and reduce discomfort. It is not intended to treat hypertension or any other condition.

How to use Rapilief 4

Take Rapilief 4 exactly as your doctor tells you. The doctor decides the dose and how long you should take it. The capsule is usually swallowed whole, and your doctor will advise whether to take it with food. Do not change the dose yourself or stop early without medical advice. If you miss a dose, ask your doctor or pharmacist what to do rather than guessing.

Side effects of Rapilief 4

Some men may notice side effects while taking Rapilief 4. The more common ones include dizziness, headache, diarrhoea, a blocked or runny nose, a drop in blood pressure on standing, and changes in ejaculation such as retrograde ejaculation. Not everyone gets these effects. Tell your doctor if any side effect bothers you or does not go away, and seek help promptly for severe dizziness or fainting.

Safety and precautions

Rapilief 4 can lower blood pressure when you stand up, especially at the start of treatment, so rise slowly. Do not take it with other alpha-blockers. Tell your eye doctor before cataract surgery, as this medicine can affect the iris during the operation. It is not for use in women or children. Ask your doctor first if you have kidney or liver problems, take other medicines, or have any allergies. The doctor will decide if it is safe for you.

Frequently asked questions

What is Rapilief 4 used for and what kind of medicine is it?

Rapilief 4 is an alpha-blocker medicine containing silodosin. It is used in men to relieve urinary signs and symptoms caused by benign prostatic hyperplasia, an enlarged prostate. It is not a blood pressure medicine, and your doctor will confirm whether it is right for you.

How should Rapilief 4 be taken?

Your doctor decides the dose and course of treatment. Swallow the capsule as instructed and do not change the dose yourself. Ask your doctor or pharmacist whether to take it with food and what to do if you miss a dose. Follow their advice closely.

What does the capsule form and 4 mg strength mean?

Rapilief 4 comes as a capsule, which is a solid dosage form you swallow. The 4 mg strength tells you how much silodosin each capsule contains. Your doctor will decide whether this strength is suitable for you; do not adjust it without medical advice.

Who should check with a doctor before taking Rapilief 4?

Ask your doctor first if you have kidney or liver problems, low blood pressure, or are planning cataract surgery. Also tell them about all other medicines you take, including those for erectile difficulties. This medicine is not for women or children.

Indications

Silodosin, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Silodosin is not indicated for the treatment of hypertension.
  • Highly effective for the treatment of Benign Prostatic Hyperplasia.
  • ... Read more
Silodosin, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Silodosin is not indicated for the treatment of hypertension.
  • Highly effective for the treatment of Benign Prostatic Hyperplasia.
  • Highest uroselectivity to alpha-1 adrenergic receptor.
  • Effective treatment option for BPH who are not responding to Tamsulosin.
  • Dose not cause Orthostatic hypotension.
  • Convenient once-daily dosing.

Pharmacology

Silodosin is a selective antagonist of post-synaptic alpha-1 adrenoreceptors, which are located in the human prostate, bladder base, bladder neck, prostatic capsule and prostatic urethra. Blockade of these alpha-1 adrenoreceptors can cause smooth muscle in these tissues to relax, resulting in an improvement in urine flow and a reduction in BPH symptoms.

Dosage & Administration

The recommended dose is Silodosin 8 mg orally once daily with a meal. 4 mg capsules taken orally once daily with a meal for those with moderate renal impairment (CrCl 30-50 mL/min).

Interaction

Strong P-glycoprotein inhibitors (e.g., cyclosporine): Co-administration may increase plasma Silodosin concentration. Concomitant use of PDE5 inhibitors with alpha-blockers including Silodosin can potentially cause symptomatic hypotension.

Contraindications

Patients with severe renal & hepatic impairment, concomitant administration with strong Cytochrome P450 3A4 (CYP3A4) inhibitors (e.g., ketoconazole, clarithromycin, itraconazole, ritonavir) and patients with a history of hypersensitivity to Silodosin.

Side Effects

Most common adverse reactions are retrograde ejaculation, dizziness, diarrhea, orthostatic hypotension, headache, nasopharyngitis and nasal congestion.

Pregnancy & Lactation

Pregnancy Category B. Silodosin is not indicated for use in women. An embryo/fetal study in rabbits showed decreased maternal body weight at 200 mg/kg/day (approximately 13-25 times the maximum recommended human exposure or MRHE of Silodosin via AUC). No statistically significant teratogenicity was observed at this dose. Silodosin was not teratogenic when administered to pregnant rats during organogenesis at 1000 mg/kg/day (estimated to be approximately 20 times the MRHE). No maternal or fetal effects were observed at this dose. Rats and rabbits do not produce glucuronidated Silodosin, which is present in human serum at approximately 4 times the level of circulating Silodosin and which has similar pharmacological activity to Silodosin. No effects on physical or behavioral development of offspring were observed when rats were treated during pregnancy and lactation at up to 300 mg/kg/day.

Precautions & Warnings

Postural hypotension with or without symptoms (e.g. dizziness) may develop when beginning Silodosin treatment. Silodosin should not be used in combination with other alpha-blocker. Inform patients planning cataract surgery to notify their ophthalmologist that they are taking Silodosin because of the possibility of Intraoperative Floppy Iris Syndrome (IFIS)

Overdose Effects

Silodosin was evaluated at doses of up to 48 mg/day in healthy male subjects. The dose-limiting adverse event was postural hypotension. Should overdose of Silodosin lead to hypotension, support of the cardiovascular system is of first importance. Restoration of blood pressure and normalization of heart rate may be accomplished by maintaining the patient in the supine position. If this measure is inadequate, administration of intravenous fluid should be considered. If necessary, vasopressors could be used, and renal function should be monitored and supported as needed. Dialysis is unlikely to be of significant benefit since Silodosin is highly (97%) protein bound.

Storage Conditions

Store at below 30°C in a dry place protected from light. Keep out of reach of Children.

Alternative brands of Silodosin

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.